Gladstone Investment (NASDAQ:GAIN) reported quarterly earnings of $0.26 per share which met the analyst consensus estimate. This is unchanged from the same period last year.
DSS Subsidiary Impact Biomedical Reports Positive Test Results For 3FDB DEET Booster Technology
Document Security Systems, Inc. (NYSE:DSS), subsidiary Impact Biomedical, Inc, along with its scientific research partner Global Research and Discovery Group Sciences,…